Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115137814 | 11513781 | 4 | F | 201607 | 20160728 | 20150916 | 20160811 | PER | US-PFIZER INC-2015295461 | PFIZER | 58.00 | YR | F | Y | 89.34000 | KG | 20160811 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115137814 | 11513781 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 115137814 | 11513781 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (2 WEEKS ON 1 WEEK OFF CYCLE EVERY 21 DAYS) | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 115137814 | 11513781 | 3 | SS | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Oral | 125 UG, UNK (EARLY MORNING 3 HOURS BEFORE EATING AND 3 HOURS AFTER OR BEFORE TAKING ANY OTHER MEDS) | U | 0 | 125 | UG | TABLET | ||||||
| 115137814 | 11513781 | 4 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 115137814 | 11513781 | 5 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | Nasal | UNK, AS NEEDED(90 MCG/ACTUATION/1-2 PUFFS AS DIRECTED EVERY 6 HOURS)/ | 0 | ||||||||||
| 115137814 | 11513781 | 6 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Nasal | UNK, AS NEEDED (90 MCG/ACTUATION/1-2 PUFFS AS DIRECTED EVERY 6 HOURS) | 0 | ||||||||||
| 115137814 | 11513781 | 7 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Nasal | UNK, AS NEEDED (90 MCG/ACTUATION/1-2 PUFFS AS DIRECTED EVERY 6 HOURS | 0 | ||||||||||
| 115137814 | 11513781 | 8 | C | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Nasal | 1 DF, DAILY (FLUTICASONE FUROATE 200 MCG AND VILANTEROL 25 MCG) | 0 | 1 | DF | ||||||||
| 115137814 | 11513781 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, DAILY | 0 | 1 | MG | TABLET | |||||||
| 115137814 | 11513781 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 125 UG, UNK (EARLY MORNING 3 HOURS BEFORE EATING AND 3 HOURS AFTER OR BEFORE TAKING ANY OTHER MEDS.) | 0 | 125 | UG | TABLET | |||||||
| 115137814 | 11513781 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 115137814 | 11513781 | 12 | C | ZOFRAN-ODT | 2 | Oral | 8 MG, AS NEEDED (EVERY 12 (TWELVE) HOURS ) | 0 | 8 | MG | TABLET | ||||||||
| 115137814 | 11513781 | 13 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MG, AS NEEDED (APPLY ROUTE AS NEEDED) | 0 | 20 | MG | |||||||||
| 115137814 | 11513781 | 14 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | 12.5 MG, UNK (12.5 MG/5 ML ELIX 60 MG) | 0 | 12.5 | MG | |||||||||
| 115137814 | 11513781 | 15 | C | NYSTATIN. | NYSTATIN | 1 | UNK (100,000 UNIT/ML SUSP 500,000 UNITS) | 0 | |||||||||||
| 115137814 | 11513781 | 16 | C | MAGNESIUM HYDROXIDE. | MAGNESIUM HYDROXIDE | 1 | UNK, 400 MG/5 ML SUSP 400 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115137814 | 11513781 | 1 | Gastrointestinal stromal tumour |
| 115137814 | 11513781 | 5 | Wheezing |
| 115137814 | 11513781 | 6 | Wheezing |
| 115137814 | 11513781 | 7 | Wheezing |
| 115137814 | 11513781 | 12 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115137814 | 11513781 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115137814 | 11513781 | Asthenia | |
| 115137814 | 11513781 | Blister | |
| 115137814 | 11513781 | Dyspepsia | |
| 115137814 | 11513781 | Dyspnoea | |
| 115137814 | 11513781 | Excoriation | |
| 115137814 | 11513781 | Fatigue | |
| 115137814 | 11513781 | Feeding disorder | |
| 115137814 | 11513781 | Gingival bleeding | |
| 115137814 | 11513781 | Hyperaesthesia | |
| 115137814 | 11513781 | Hypogeusia | |
| 115137814 | 11513781 | Jaundice | |
| 115137814 | 11513781 | Leukopenia | |
| 115137814 | 11513781 | Lip blister | |
| 115137814 | 11513781 | Lip dry | |
| 115137814 | 11513781 | Mucosal inflammation | |
| 115137814 | 11513781 | Neutropenia | |
| 115137814 | 11513781 | Pain | |
| 115137814 | 11513781 | Palmar-plantar erythrodysaesthesia syndrome | |
| 115137814 | 11513781 | Perineal pain | |
| 115137814 | 11513781 | Rash | |
| 115137814 | 11513781 | Skin exfoliation | |
| 115137814 | 11513781 | Stomatitis | |
| 115137814 | 11513781 | Thrombocytopenia | |
| 115137814 | 11513781 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115137814 | 11513781 | 1 | 20150801 | 0 |